Medical Devices Startups

Rosetta Omics is a deeptech healthcare startup combining spatial multiomics profiling and AI to advance precision medicine in oncology. It develops technology for cancer diagnostics and clinical research, supported by a team of scientists, clinicians, and oncology experts.

1 investor

Roshal Health operates a technology-enabled platform that connects healthcare providers with medical professionals for on-demand delivery of diagnostic imaging services and other healthcare staffing needs. Founded in 2005, the company has expanded from its Texas base to serve providers across the United States.

1 investor

Roshan Water develops water-testing technology, drawing on scientific research and commercialization expertise to move lab innovations into practical field-deployable systems. The company serves users who need water quality assessment capabilities.

1 investor

Route 92 Medical develops medical devices and procedural solutions for patients undergoing neurovascular intervention. The company was founded by physicians and collaborates with leading clinicians to address key challenges in neurointerventional surgery.

1 investor

ROWIAK worked on laser-based solutions for eye care in the field of ophthalmology. The site now indicates the company has closed and redirects visitors to a personal site of Holger Lubatschowski.

1 investor

Riverpoint Medical appears to be a medical device or healthcare-focused company with resources available for download, though the page does not provide sufficient detail about what the company specifically does or its customer base.

1 investor

RQM+ provides services to the medical device industry, leveraging executive expertise in clinical trials, regulatory affairs, quality management, laboratory operations, and reimbursement.

1 investor

RS Research develops polymer-drug conjugates for targeted chemotherapy and theranostics in oncology, aiming to improve the therapeutic index in cancer treatment. The company's platform technology addresses the efficacy-toxicity trade-off challenge in targeted therapies.

1 investor

Rx Bandz develops auto-injector devices and injectable formulations for treatment conditions including anaphylaxis, diabetes, opioid overdose, and other medical emergencies for patients, first responders, and military personnel.

1 investor

SAB BIO is a clinical-stage biopharmaceutical company developing multi-specific human immunoglobulin G (hIgG) therapies to treat and prevent immune and autoimmune disorders, using genetically engineered transchromosomic cattle to produce therapeutic candidates. The company has advanced its lead candidate SAB-142 for Type 1 Diabetes into Phase 2b clinical trials.

1 investor

SafeBeat uses engineering and machine learning to develop solutions for cardiac care and arrhythmia management. The company serves cardiologists, electrophysiologists, and healthcare organizations.

1 investor

SafeBVM develops flow-limiting devices and monitoring systems for manual bag-valve-mask ventilation used in emergency and critical care settings. The company's products help healthcare providers deliver consistent, patient-safe ventilation in cardiac arrest, overdose, and brain injury scenarios.

1 investor

Safe Health Systems provides digital health software and platform services that enable low-acuity care delivery at home, targeting healthcare providers and clinics to improve patient engagement and access in rural and underserved areas.

1 investor

SageMedic is a California-licensed clinical laboratory providing cancer treatment testing and diagnostics through its SAGE Oncotest™ platform. The company serves oncologists and cancer patients seeking more effective preoperative care approaches.

1 investor

SageSpectra develops optical sensing and AI tools for clinicians, including technology for peripheral artery disease (PAD) screening and monitoring to prevent flap failures. The company targets healthcare providers with real-time diagnostic and patient monitoring solutions.

1 investor

Sahlgrenska Science Park is an accelerator and innovation hub that supports life science and health technology companies, located at the Sahlgrenska medical campus in Gothenburg, Sweden. It facilitates collaboration between researchers, clinicians, entrepreneurs, and industry partners to develop and scale healthcare innovations.

1 investor

Sakura MedTech develops a tampon-shaped imaging device as a comfortable alternative to the speculum for cervical cancer screening and gynecological exams. The device aims to reduce patient discomfort, anxiety, and no-shows while maintaining clinical standards in women's healthcare.

1 investor

Salution Health is a human- and AI-powered health accelerator that helps healthcare organizations manage the full lifecycle of diagnostic and therapeutic products, including AI-enabled devices, software as a medical device, and cell and gene-based products. Its services span unmet needs identification, preclinical development, manufacturing, clinical trial design, regulatory strategy and submissions, quality systems, and post-market surveillance, supported by an agentic AI platform and a senior operating team.

1 investor

SampleFacts develops microsampling devices for simplified blood cell and plasma collection, targeting researchers, clinical study professionals, and healthcare providers. The company builds on university research to enable easier, faster, and more reliable blood sampling for research, clinical studies, and diagnostics.

1 investor

Sanavia discovers novel cancer-specific epitopes using proprietary immunization technology and AI to enable more effective antibody therapies for oncology. The company develops epitope discovery platforms and antibody drug candidates targeting multiple cancer types to expand treatment options for patients.

1 investor

SaniSure develops Mixed4Sure, a single-use mixing platform for small-volume biopharmaceutical processing that handles volumes from 50 mL to 20 L with reduced shear forces and lower capital costs than traditional stainless-steel systems.

1 investor

Sanmirna Therapeutics develops microRNA-targeted therapeutics for cancer treatment, with its lead candidate Miristen™ currently in Phase I clinical trials for acute myeloid leukemia. The company leverages microRNA discovery to create novel oncology treatments.

1 investor

Sanolla develops AI-powered digital stethoscopes and wearable devices that analyze full-spectrum body sounds including infrasound for diagnostic and home monitoring applications. The company serves healthcare professionals and chronic disease patients in primary care, cardiology, and pulmonology with real-time diagnostic insights and early detection capabilities.

1 investor

Sanos provides clinical trial management services for pharmaceutical sponsors across multiple therapeutic areas, offering end-to-end capabilities from protocol development through regulatory approval. The company operates as a strategic partner for drug development, managing patient recruitment, data integrity, and operational execution with fixed budgets and timelines.

1 investor